FDA
approval
· 2022-03-17
FDA Approved: LACOSAMIDE — Original Application (Glenmark Pharmaceuticals Inc. USA)
Summary
The FDA approved Glenmark’s lacosamide as an original generic drug application (ANDA); lacosamide is an anticonvulsant used to treat partial-onset seizures in e…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for LACOSAMIDE (LACOSAMIDE)